A Chinese drugmaker, which is collaborating with AstraZeneca PLC on production of a coronavirus vaccine, has won approval from Chinese regulators to start testing one of its own vaccine candidates at home. Shenzhen Kangtai Biological Products Co., one of the world’s largest producers of hepatitis B vaccines, said Tuesday in a stock-exchange filing it will begin testing its coronavirus vaccine candidate on people immediately, after it was found to protect mice and monkeys from the new virus.

Source: Wall Street Journal September 30, 2020 06:00 UTC